Defense and Liberation is the eleventh and final mainline expansion for the Il-2 Sturmovik: Great Battles series.

Merck & Co/MSD has agreed to buy Pandion for $1.85 billion, bolting on a pipeline of drugs for autoimmune and other immunological disorders headed by interleukin-2 (IL-2) based therapy PT-101.

All the Latest Game Footage and Images from IL-2 Sturmovik: Battle of Stalingrad - Spitfire Mk.XIVe with Teardrop Canopy The Spitfire Mk. XIV was originally built with a “high back” rear ...

from the Utrecht Medical Centre in The Netherlands provides the first clinical evidence, to the authors' knowledge, that local interleukin-2 (IL-2) therapy in combination with radiotherapy is an ...

Despite setbacks for projects trying to harness the power of the cytokine interleukin-2 (IL-2) as a cancer therapy, there are still plenty of players on the field – and Roche has just joined ...

All the Latest Game Footage and Images from IL-2 Sturmovik: Flying Circus - Volume III Flying Circus: Volume III expands the WWI aerial lineup to the early war period, when the war in the skies ...

X-linked severe combined immunodeficiency disease (X-SCID) is a rare genetic disorder characterized by profound defects in T-cell, B-cell, and natural ...

A new study, published today in mBio, employed a novel strategy to halt progression of rheumatic heart disease in a preclinical model by using low-dose interleukin 2 (LD-IL-2). IL-2 is a hormone of ...

INNOVENT BIO (01801.HK) is working with a consultant to gauge the interest of global pharmaceutical companies in its ...